May 1, 2026 - 08:19

Public transit agencies across the country are missing a critical opportunity to sell their value to lawmakers, according to a new report. The study argues that the link between reliable public transportation and improved public health is clear, but transit operators are not doing enough to make that case to policy makers. The report suggests that when cities invest in robust bus and rail systems, the return on investment goes far beyond reduced traffic congestion.
The core argument is simple: good public transit leads to better health outcomes. People who use transit tend to walk more, reducing rates of obesity and heart disease. Reliable bus and train service also ensures that low-income residents and seniors can reach medical appointments, pharmacies, and grocery stores. Without that access, chronic conditions worsen, and emergency room visits increase. The report points to data showing that communities with underfunded transit systems see higher rates of asthma and other respiratory issues, partly due to increased car emissions.
The problem, the report states, is that transit agencies often frame their funding requests around commute times or economic development. They rarely highlight the direct health savings for the public. The authors argue that this is a strategic mistake. By framing transit as a public health investment, agencies could tap into healthcare budgets and federal wellness grants. The report calls for a shift in messaging: instead of just moving people, transit should be sold as a tool for preventing disease and cutting healthcare costs. Without that narrative, the report warns, funding will remain inadequate, and public health will suffer.
June 15, 2026 - 10:53
Indiana takes on powerful hospitals by capping prices they charge employersIndiana, a reliably Republican state, is taking an unusual step to tackle soaring healthcare costs. Frustrated by the financial strain on its employers, the state government is imposing price caps...
June 14, 2026 - 18:08
Teladoc Health (TDOC) Stock Valuation As Analyst Sentiment Improves Despite Expected Earnings DeclineTeladoc Health (TDOC) is drawing renewed attention from investors after analysts revised their earnings estimates upward, signaling a shift in sentiment. Despite this more optimistic outlook, the...
June 14, 2026 - 07:18
Middle-aged adults taking GLP-1s for obesity can save over $192K on lifetime medical costs, higher if they don’t have college degrees, new study findsA new study suggests that middle-aged adults who take GLP-1 medications for obesity could save more than $192,000 in lifetime medical expenses. The savings are even higher for those without a...
June 13, 2026 - 18:51
Column: New federal rules threaten scientific researchNew federal guidelines for research funding are raising alarms across the scientific community. The proposed changes, which include tighter political oversight and topic restrictions, could slow...